With science, compassion, and purpose, we are Powering Recovery, Renewing Hope. 

View All
Indivior-home-carousel-coat
Indivior-home-carousel-rachel
Indivior-home-carousel-eddie
Indivior-home-carousel-logo
Indivior-home-carousel-keith-hands
Indivior-home-carousel-science
Who we are

We’re Supporting Long-Term Recovery for Those Affected by OUD

Indivior is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. For more than 25 years, we have revolutionized the science of addiction medicine — developing treatments that help people move toward long-term recovery with independence and dignity.

Our commitment is unwavering: to expand access to effective treatment, dismantle stigma, and empower every person living with OUD to define their lives beyond the disease.

Explore our company

2.0 Million

Received Buprenorphine Medication Assisted Treatment (BMAT)1

4.8 Million

People diagnosed with OUD in the U.S.2

7.8 Million

People misuse opioids in the U.S.2

How We Make a Difference

Powering Recovery, Renewing Hope

We partner with scientists, communities, clinicians, policymakers, people living with OUD, and caregivers to advance access to evidence-based treatment for OUD, dismantle stigma, and elevate the lived experience of individuals in recovery. Together, we are advancing recovery for OUD — one life, one family, and one community at a time. 

Explore our impact
What we do

Explore how we are changing recovery

Our vision is that millions of people across the globe suffering from opioid use disorder have access to evidence-based treatment to change lives.

Our Products

Our Products

Our products are rooted in science, compassion and an unwavering commitment to help people with opioid use disorder (OUD) achieve long-term recovery.

Learn more
Our Science

Our Science

We lead the way in developing long-term treatment options for people who suffer from opioid use disorder (OUD), addressing the most urgent public health challenges of our time.

Learn more
Our Impact

Our Impact

We advocate for systemic change by working with policymakers, healthcare systems, justice institutions, and advocacy groups to eliminate stigma and barriers to OUD recovery.

Learn more
Our Focus

Our Focus

Our focus is singular and unwavering: to transform the lives of people affected by opioid use disorder (OUD) through the power of science, compassion, and advocacy. 

Learn more

1. Symphony and Indivior analytics, patient treated over the last twelve months. 

Privacy Preference Center

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.

Privacy Policy Cookie Notice

Manage Consent Preferences

Always Active

These cookies are essential for the website to function, such as navigating secure areas, remembering your privacy preferences, or keeping items in a shopping cart. They cannot be switched off.

These cookies help us understand how visitors interact with the website, allowing us to measure and improve performance (e.g., Google Analytics). Data is anonymized.

These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.